Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing

Introduction: Antiarrhythmic drug therapy can affect pacemaker parameters in both the atrial and ventricular myocardium. It is not known whether antiarrhythmic drugs impact His bundle pacing/sensing parameters and His to ventricle (H-V) intervals following permanent His bundle pacing (HBP). The aims...

Full description

Bibliographic Details
Main Authors: Lan Su, Xue Xia, Dongjie Liang, Shengjie Wu, Lei Xu, Tiancheng Xu, Songjie Wang, Xiao Chen, Weijian Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.585165/full
_version_ 1818438663598505984
author Lan Su
Lan Su
Xue Xia
Xue Xia
Dongjie Liang
Dongjie Liang
Shengjie Wu
Shengjie Wu
Lei Xu
Lei Xu
Tiancheng Xu
Tiancheng Xu
Songjie Wang
Songjie Wang
Xiao Chen
Xiao Chen
Weijian Huang
Weijian Huang
author_facet Lan Su
Lan Su
Xue Xia
Xue Xia
Dongjie Liang
Dongjie Liang
Shengjie Wu
Shengjie Wu
Lei Xu
Lei Xu
Tiancheng Xu
Tiancheng Xu
Songjie Wang
Songjie Wang
Xiao Chen
Xiao Chen
Weijian Huang
Weijian Huang
author_sort Lan Su
collection DOAJ
description Introduction: Antiarrhythmic drug therapy can affect pacemaker parameters in both the atrial and ventricular myocardium. It is not known whether antiarrhythmic drugs impact His bundle pacing/sensing parameters and His to ventricle (H-V) intervals following permanent His bundle pacing (HBP). The aims of the study were to prospectively determine the influence of rhythm and rate-controlling drugs on pacing parameters and H-V conduction after His bundle lead implantation and to assess the impact of rhythm and rate-controlling drugs on the safety of HBP.Materials and Methods: Patients (N = 140) with QRS duration < 120 ms who met permanent pacing indications were prospectively enrolled. Propafenone, lidocaine, and adenosine were injected intravenously after implantation of 3,830 lead during the procedure. Metoprolol succinate, amiodarone, and digoxin were taken orally for 1 month. Pacing parameters before and after drug intervention was measured, including His capture threshold, sensing and impedance, H-V interval, and conduction.Results: There were no statistically significant differences in His bundle pacing thresholds, impedance, and sensing after drug intervention at implantation or during a 2-month follow-up (P > 0.05). The HV interval was not affected except in the large-dose propafenone group where HV interval prolonged (P = 0.001). All patients maintained 1:1 H-V conduction following drug administration.Conclusion: There was no adverse impact on the HBP parameters or H-V conduction after the administration of commonly used dosage of rhythm and rate-controlling drugs. The drugs were safe in patients with permanent His bundle pacing.
first_indexed 2024-12-14T17:44:09Z
format Article
id doaj.art-d08548d8b0c9401e969fb139de7d0e9f
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-14T17:44:09Z
publishDate 2020-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-d08548d8b0c9401e969fb139de7d0e9f2022-12-21T22:52:46ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-12-01710.3389/fcvm.2020.585165585165Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle PacingLan Su0Lan Su1Xue Xia2Xue Xia3Dongjie Liang4Dongjie Liang5Shengjie Wu6Shengjie Wu7Lei Xu8Lei Xu9Tiancheng Xu10Tiancheng Xu11Songjie Wang12Songjie Wang13Xiao Chen14Xiao Chen15Weijian Huang16Weijian Huang17Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaDepartment of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaThe Key Lab of Cardiovascular Disease, Science and Technology of Wenzhou, Wenzhou, ChinaIntroduction: Antiarrhythmic drug therapy can affect pacemaker parameters in both the atrial and ventricular myocardium. It is not known whether antiarrhythmic drugs impact His bundle pacing/sensing parameters and His to ventricle (H-V) intervals following permanent His bundle pacing (HBP). The aims of the study were to prospectively determine the influence of rhythm and rate-controlling drugs on pacing parameters and H-V conduction after His bundle lead implantation and to assess the impact of rhythm and rate-controlling drugs on the safety of HBP.Materials and Methods: Patients (N = 140) with QRS duration < 120 ms who met permanent pacing indications were prospectively enrolled. Propafenone, lidocaine, and adenosine were injected intravenously after implantation of 3,830 lead during the procedure. Metoprolol succinate, amiodarone, and digoxin were taken orally for 1 month. Pacing parameters before and after drug intervention was measured, including His capture threshold, sensing and impedance, H-V interval, and conduction.Results: There were no statistically significant differences in His bundle pacing thresholds, impedance, and sensing after drug intervention at implantation or during a 2-month follow-up (P > 0.05). The HV interval was not affected except in the large-dose propafenone group where HV interval prolonged (P = 0.001). All patients maintained 1:1 H-V conduction following drug administration.Conclusion: There was no adverse impact on the HBP parameters or H-V conduction after the administration of commonly used dosage of rhythm and rate-controlling drugs. The drugs were safe in patients with permanent His bundle pacing.https://www.frontiersin.org/articles/10.3389/fcvm.2020.585165/fullhis bundle pacing (HBP)antiarrhythmic drugsH-V conductionsafetypacing parametersrhythm and rate-controlling
spellingShingle Lan Su
Lan Su
Xue Xia
Xue Xia
Dongjie Liang
Dongjie Liang
Shengjie Wu
Shengjie Wu
Lei Xu
Lei Xu
Tiancheng Xu
Tiancheng Xu
Songjie Wang
Songjie Wang
Xiao Chen
Xiao Chen
Weijian Huang
Weijian Huang
Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing
Frontiers in Cardiovascular Medicine
his bundle pacing (HBP)
antiarrhythmic drugs
H-V conduction
safety
pacing parameters
rhythm and rate-controlling
title Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing
title_full Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing
title_fullStr Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing
title_full_unstemmed Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing
title_short Effects of Rhythm and Rate-Controlling Drugs in Patients With Permanent His-Bundle Pacing
title_sort effects of rhythm and rate controlling drugs in patients with permanent his bundle pacing
topic his bundle pacing (HBP)
antiarrhythmic drugs
H-V conduction
safety
pacing parameters
rhythm and rate-controlling
url https://www.frontiersin.org/articles/10.3389/fcvm.2020.585165/full
work_keys_str_mv AT lansu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT lansu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT xuexia effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT xuexia effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT dongjieliang effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT dongjieliang effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT shengjiewu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT shengjiewu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT leixu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT leixu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT tianchengxu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT tianchengxu effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT songjiewang effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT songjiewang effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT xiaochen effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT xiaochen effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT weijianhuang effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing
AT weijianhuang effectsofrhythmandratecontrollingdrugsinpatientswithpermanenthisbundlepacing